CTKB
Cytek Biosciences, Inc. · Healthcare · Medical - Devices
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +4.6% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 74 | 0 | 60.52M | $268.04M | +6 | −6 |
| Q1 2026 | 76 | +1 | 60.92M | $266.22M | +4 | −3 |
| Q4 2025 | 75 | -1 | 61.04M | $308.28M | — | −1 |
| Q3 2025 | 19 | +4 | 43.35M | $150.42M | +4 | — |
| Q2 2025 | 12 | 0 | 36.22M | $123.14M | +1 | −1 |
| Q1 2025 | 9 | 0 | 9.63M | $38.61M | +1 | −1 |
| Q4 2024 | 9 | +1 | 10.70M | $69.47M | +1 | — |
| Q3 2024 | 7 | 0 | 5.47M | $30.29M | — | — |
| Q2 2024 | 7 | — | 6.05M | $33.76M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 17.04M | — | $57.92M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 17.04M | — | $57.92M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 17.04M | — | $57.92M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 17.04M | — | $57.92M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 17.04M | — | $57.92M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 17.04M | — | $57.92M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 17.04M | — | $57.92M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 17.04M | — | $57.92M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 17.04M | — | $57.92M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 17.04M | — | $57.92M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 17.04M | — | $57.92M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 17.04M | — | $57.92M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passief) | 7.77M | — | $26.40M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passief) | 7.77M | — | $26.40M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 7.77M | — | $26.40M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 7.77M | — | $26.40M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 7.77M | — | $26.40M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (passief) | 4.17M | -4.8% | $14.19M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passief) | 2.73M | +1.6% | $9.28M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passief) | 2.73M | +1.6% | $9.28M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 1.24M | +89.6% | $4.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 1.24M | +89.6% | $4.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 1.24M | +89.6% | $4.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 1.24M | +89.6% | $4.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 1.24M | +89.6% | $4.21M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Renaissance Technologies ✦ | 1.06M | +54.6% | $3.61M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 27 | Millennium Management ✦ | 924.77K | +86.7% | $3.14M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 617.09K | +2.4% | $2.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 617.09K | +2.4% | $2.10M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Marshall Wace ✦ | 261.35K | Nieuw | $888,596 | 0.0% | New | 1 | SEC ↗ |
| 31 | Marshall Wace ✦ | 261.35K | Nieuw | $888,596 | 0.0% | New | 1 | SEC ↗ |
| 32 | Fidelity (FMR) ✦ | 205.74K | — | $699,519 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Arrowstreet Capital ✦ | 144.25K | +199.6% | $490,457 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 34 | T. Rowe Price ✦ | 56.82K | +6.5% | $194,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Marshall Wace | $888,596 | 0.0% |
| Marshall Wace | $888,596 | 0.0% |
Verlaten
| Point72 Asset Management | $70,159 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 164 houders, 84.77M aandelen, $364.62M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.